If their growth assumptions are hit, I think Cipher trades to at least $16 CAD/share at a 8x run rate of FCF. Size puts us into the realm of small cap funds. Add net cash + buybacks, and we could be looking at a $25 stock here in a few years.
He’ll probably get fed a bunch of vile shit and that comes cheap. Just like the Culpeppers dirty laundry. $89M USD was cheap for that asset but that insecticide was also on our crops since the 90’s. As far as I’m concerned Craig’s stock price deserves to be at $0 CAD.
Dean, please just take it into consideration about what I'm saying. Craig just lied to everyone for 5+ years about a license after modeling what they expected to sell up in Canada in a SIB which they distributed to everyone. Now seriously look at what Can-Fite Biopharma did to themselves a decade ago with rheumatoid arthritis. That's their next license that's exposed to a P3 in the psoriasis trial. Just like Moberg's product- that thing looks like it works for psoriasis, but I don't have insight into the trial design. Piclidenoson in that RA trial was statistically significant to a placebo, and they chopped off their own head by intentionally withholding the molecule for some reason. Moberg's story is no different. Everything that surrounds Craig's business is acting dirty as sin.
Cipher Pharmaceuticals could very well be a very good stock pick, but your executive is lying about every single thing they've done. Every single person that just caught up in that bullshit about a label was horrendously gas lit on purpose...
If their growth assumptions are hit, I think Cipher trades to at least $16 CAD/share at a 8x run rate of FCF. Size puts us into the realm of small cap funds. Add net cash + buybacks, and we could be looking at a $25 stock here in a few years.
dontgivemehope.gif lol
#ontrack
Would love to see an updated price target!
Thanks. I'll put that on my list of posts to work on.
He’ll probably get fed a bunch of vile shit and that comes cheap. Just like the Culpeppers dirty laundry. $89M USD was cheap for that asset but that insecticide was also on our crops since the 90’s. As far as I’m concerned Craig’s stock price deserves to be at $0 CAD.
i hope it isn't a zero. it's my biggest position. i have two kids to feed and a energy addiction to support.
Same here. 2 small kids + wife = need Cipher at 50 CAD/share
Dean, please just take it into consideration about what I'm saying. Craig just lied to everyone for 5+ years about a license after modeling what they expected to sell up in Canada in a SIB which they distributed to everyone. Now seriously look at what Can-Fite Biopharma did to themselves a decade ago with rheumatoid arthritis. That's their next license that's exposed to a P3 in the psoriasis trial. Just like Moberg's product- that thing looks like it works for psoriasis, but I don't have insight into the trial design. Piclidenoson in that RA trial was statistically significant to a placebo, and they chopped off their own head by intentionally withholding the molecule for some reason. Moberg's story is no different. Everything that surrounds Craig's business is acting dirty as sin.
Cipher Pharmaceuticals could very well be a very good stock pick, but your executive is lying about every single thing they've done. Every single person that just caught up in that bullshit about a label was horrendously gas lit on purpose...